Expert Insights

By Julie Gould  Jenn Zerbato, PhD, post-doctoral research fellow, Peter Doherty Institute for Infection and Immunity, breaks down why HIV RNA could serve as a better measure of efficient latency reversal in both pre-clinical and clinical assessment of latency reversing agents (LRAs). What…

While the COVID-19 pandemic has resulted in increased morbidity and mortality rates on a global scale, it has also exacerbated and brought the mental health crisis to the forefront. More than ever, people are seeking mental health services and experts believe a population-based approach could be…

There will be little nostalgia associated with placing 2020 in rearview mirror for most health care stakeholders. Especially on the financial front, the year has left provider organizations with unprecedented challenges that will likely follow them well into 2021. One report released in September…

As COVID-19 spurs expansion of payer telehealth offerings, some say initiatives begun during the pandemic could become the norm. In 2020, the COVID-19 pandemic quickened the adoption of telehealth as many members turned to remote, virtual care services as a way of managing their health while…

The American Rescue Plan recently signed into law includes an incentive to encourage states to expand Medicaid. Will any of the 12 holdout states broaden their program for the needy, or do political divisions run so deep that compromise is out of the question? President Joe Biden has signed the $1…

By Julie Gould  Anthony Costello, president of Patient Cloud at Medidata, discusses challenges facing clinical trials with regard to sensor and data usage, and explores a solution that will help lower costs and enable greater operational efficiency by making it easier for patients to share data…

Lung cancer remains the second most common cancer in both men and women in the United States with an estimated 235,760 adults (119,100 men and 116,660 women)1 expected to be diagnosed in 2021. There are two main types of lung cancer including the more prevalent non-small cell lung cancer and small…

By Julie Gould Shephard Mpofu, MD, senior vice president and chief medical officer, Novartis Gene Therapies, discusses various trials—SPR1NT, LTFU, and RESTORE from Muscular Dystrophy Association Virtual Clinical and Scientific conference—that examined a treatment for spinal muscular atrophy (SMA…

By Icario Team  As individual states and health plans are focusing heavily on Medicaid CAHPS surveys, here are 3 considerations to make when engaging your Medicaid members that boost member experience. Creating positive member experiences for health plan members is a proven way to boost CAHPS…

Matthew Michela, president and CEO, Life Image, offers advice to payers regarding the impending enforcement of HHS interoperability rules and handling advanced data, as well as explains how the COVID-19 pandemic has made the need for cloud-based data critical.